Alyeska Investment Group’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-52,500
| Closed | -$6.23M | – | 700 |
|
2022
Q1 | $6.23M | Buy |
+52,500
| New | +$6.23M | 0.07% | 263 |
|
2021
Q4 | – | Sell |
-60,954
| Closed | -$8.47M | – | 822 |
|
2021
Q3 | $8.47M | Buy |
+60,954
| New | +$8.47M | 0.1% | 225 |
|
2020
Q1 | – | Sell |
-60,934
| Closed | -$3.32M | – | 525 |
|
2019
Q4 | $3.32M | Buy |
60,934
+10,233
| +20% | +$557K | 0.04% | 243 |
|
2019
Q3 | $2.12M | Sell |
50,701
-144,545
| -74% | -$6.03M | 0.03% | 266 |
|
2019
Q2 | $8.55M | Buy |
+195,246
| New | +$8.55M | 0.11% | 178 |
|
2017
Q3 | – | Sell |
-149,651
| Closed | -$3.74M | – | 579 |
|
2017
Q2 | $3.74M | Buy |
+149,651
| New | +$3.74M | 0.03% | 288 |
|